MedAvail Holdings, Inc. (MDVL)

Expands MedAvail's presence among Federally Qualified Health Centers (FQHCs) Expands MedAvail's presence among Federally Qualified Health Centers (FQHCs)

PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 with the Securities and Exchange Commission.

Initial three deployments to be completed in early 2024 at ASP Cares Pharmacy in Las Vegas Agreement repsents expansion of successful relationship with Dallas-based Oak Lawn Pharmacy PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with Pharmacy Fund 1 for the deployment of ten M4 MedCenter kiosks, which will be serviced by ASP Cares Pharmacy. Pharmacy Fund 1 also operates Oaklawn Pharmacy, which is a current MedAvail partner in Dallas, Texas.

PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023.

Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to be deployed within 24 months of contract execution

PHOENIX, Ariz., July 31, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-50. The reverse stock split will become effective at 5:00 p.m. Eastern time, on July 31, 2023. The Company's common stock will begin trading on a post-split basis at the market open on August 1, 2023, under the Company's existing trading symbol “MDVL”. The CUSIP number for the common stock following the reverse stock split will be 58406B 202. The reverse stock split is part of the Company's plan to regain compliance with the Minimum Bid Price Requirement of $1.00 per share for continued listing on The Nasdaq Capital Market.

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q1 2023 Results Conference Call May 18, 2023 4:30 PM ET Company Participants Steve Halper - Managing Director at LifeSci Advisors Mark Doerr - Chief Executive Officer Ramona Seabaugh - Chief Financial Officer Conference Call Participants Lucas Romanski - TD Cowen Operator Hello, everyone. And thank you for joining MedAvail's 2023 First Quarter Conference Call.

Management to host investor conference call and webcast at 4:30pm EDT today Management to host investor conference call and webcast at 4:30pm EDT today

Management to host investor conference call and webcast at 4:30 pm EDT today Management to host investor conference call and webcast at 4:30 pm EDT today

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q4 2022 Earnings Conference Call April 13, 2023 4:30 PM ET Company Participants Steven Halper - MD, LifeSci Advisors, IR Mark Doerr - CEO Ramona Seabaugh - CFO Conference Call Participants Charles Rhyee - Cowen & Co. Operator Hello, everyone, and thank you for joining the MedAvail's 2022 Fourth Quarter and Full Year Conference Call. My name is Doug.

Management to host investor conference call and webcast at 4:30pm EDT on that day Management to host investor conference call and webcast at 4:30pm EDT on that day

Management to host investor conference call and webcast at 4:30pm ET on that day Management to host investor conference call and webcast at 4:30pm ET on that day

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. Here's the latest list of major oversold players in this sector.

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Ji-Yon Yi - IR Mark Doerr - CEO Ramona Seabaugh - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Hello, everyone, and thank you for joining the MedAvail's 2022 Third Quarter Earnings Conference Call. My name is Daren, I'll be your operator for today.

MISSISSAUGA, Ontario & PHOENIX, Ariz.

MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference in New York. MedAvail's management is scheduled to present on Tuesday, September 13, 2022, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Invest